STOCK TITAN

AppYea Launches Smart Biofeedback-Based Wristband to Address Snoring

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

AppYea Inc. (OTCQB: APYP) has launched AppySleep, an innovative wearable solution to address snoring and monitor sleep apnea. The device consists of a smart biofeedback-based wristband that connects to an app on iPhone or Android. It detects snoring and activates gentle vibrations to prompt users to change their sleeping position.

Key features include:

  • AI-powered customization of snoring treatment
  • Detection of irregular breathing patterns
  • Personal cloud access for sleep history and statistics
  • Introductory price of $149

AppYea is also developing AppySleep LAB, a touchless app for diagnosing sleep apnea without overnight lab stays. The company plans to pre-submit an FDA request for AppySleep LAB in H1 2025. Market projections indicate significant growth potential in the sleep tech and anti-snoring treatment sectors.

AppYea Inc. (OTCQB: APYP) ha lanciato AppySleep, una soluzione indossabile innovativa per affrontare il russare e monitorare l'apnea notturna. Il dispositivo è costituito da un braccialetto intelligente basato sul biofeedback che si connette a un'app su iPhone o Android. Rileva il russare e attiva vibrazioni delicate per invitare gli utenti a cambiare posizione nel sonno.

Le caratteristiche principali includono:

  • Personalizzazione del trattamento per il russare alimentata dall'AI
  • Rilevamento di schemi di respirazione irregolari
  • Accesso a cloud personale per la storia del sonno e statistiche
  • Prezzo introduttivo di $149

AppYea sta anche sviluppando AppySleep LAB, un'app senza contatto per la diagnosi dell'apnea notturna senza dover pernottare in laboratorio. L'azienda prevede di inviare una richiesta FDA per AppySleep LAB nel primo semestre del 2025. Le proiezioni di mercato indicano un notevole potenziale di crescita nei settori della tecnologia del sonno e del trattamento contro il russare.

AppYea Inc. (OTCQB: APYP) ha lanzado AppySleep, una solución portátil innovadora para abordar el ronquido y monitorear la apnea del sueño. El dispositivo consiste en una pulsera inteligente basada en biofeedback que se conecta a una aplicación en iPhone o Android. Detecta el ronquido y activa vibraciones suaves para invitar a los usuarios a cambiar de posición al dormir.

Las características clave incluyen:

  • Personalización del tratamiento del ronquido impulsada por IA
  • Detección de patrones de respiración irregulares
  • Acceso a la nube personal para el historial del sueño y estadísticas
  • Precio introductorio de $149

AppYea también está desarrollando AppySleep LAB, una aplicación sin contacto para diagnosticar apnea del sueño sin necesidad de pernoctar en un laboratorio. La compañía planea presentar una solicitud a la FDA para AppySleep LAB en la primera mitad de 2025. Las proyecciones de mercado indican un gran potencial de crecimiento en los sectores de tecnología del sueño y tratamiento del ronquido.

AppYea Inc. (OTCQB: APYP)는 코골이 문제를 해결하고 수면 무호흡증을 모니터링하기 위한 혁신적인 웨어러블 솔루션인 AppySleep을 출시했습니다. 이 장치는 iPhone 또는 Android의 앱에 연결되는 스마트 바이오피드백 기반 손목밴드로 구성되어 있습니다. 코골이를 감지하고 부드러운 진동을 활성화하여 사용자가 잠자는 자세를 바꾸도록 유도합니다.

주요 특징은 다음과 같습니다:

  • AI 기반의 코골이 치료 맞춤화
  • 불규칙한 호흡 패턴 감지
  • 수면 이력 및 통계에 대한 개인 클라우드 접근
  • 시장 출시 가격 $149

AppYea는 또한 숙면 무호흡증을 진단하기 위한 비접촉식 앱인 AppySleep LAB를 개발 중입니다. 이 회사는 2025년 상반기 내에 AppySleep LAB에 대한 FDA 요청을 제출할 계획입니다. 시장 전망은 수면 기술 및 코골이 치료 분야에서의 상당한 성장 잠재력을 나타냅니다.

AppYea Inc. (OTCQB: APYP) a lancé AppySleep, une solution portable innovante pour traiter le ronflement et surveiller l'apnée du sommeil. L'appareil se compose d'un bracelet intelligent basé sur le biofeedback qui se connecte à une application sur iPhone ou Android. Il détecte le ronflement et active des vibrations douces pour inciter les utilisateurs à changer de position pendant leur sommeil.

Les caractéristiques clés incluent :

  • Personnalisation du traitement du ronflement alimentée par l'IA
  • Détection des schémas respiratoires irréguliers
  • Accès à un cloud personnel pour l'historique du sommeil et les statistiques
  • Prix d'introduction de 149 $

AppYea développe également AppySleep LAB, une application sans contact pour diagnostiquer l'apnée du sommeil sans avoir besoin de rester au laboratoire pendant la nuit. L'entreprise prévoit de soumettre une demande à la FDA pour AppySleep LAB au premier semestre de 2025. Les prévisions du marché indiquent un potentiel de croissance significatif dans les secteurs de la technologie du sommeil et du traitement contre le ronflement.

AppYea Inc. (OTCQB: APYP) hat AppySleep auf den Markt gebracht, eine innovative tragbare Lösung zur Bekämpfung von Schnarchen und zur Überwachung der Schlafapnoe. Das Gerät besteht aus einem intelligenten biofeedback-basierten Armband, das mit einer App auf iPhone oder Android verbunden werden kann. Es erkennt Schnarchen und aktiviert sanfte Vibrationen, um die Benutzer zu ermutigen, ihre Schlafposition zu ändern.

Zu den wichtigsten Funktionen gehören:

  • KI-gesteuerte Anpassung der Schnarchbehandlung
  • Erkennung unregelmäßiger Atemmuster
  • Persönlicher Cloud-Zugang zur Schlafhistorie und Statistiken
  • Einführungspreis von 149 $

AppYea entwickelt auch AppySleep LAB, eine berührungslose App zur Diagnose von Schlafapnoe ohne einen Übernachtungstest im Labor. Das Unternehmen plant, im ersten Halbjahr 2025 einen Antrag bei der FDA für AppySleep LAB einzureichen. Marktprognosen zeigen ein erhebliches Wachstumspotenzial im Bereich Schlaftechnologie und Behandlung gegen Schnarchen.

Positive
  • Launch of AppySleep, an innovative wearable solution for snoring and sleep apnea monitoring
  • AI-powered customization for snoring treatment
  • Development of AppySleep LAB for touchless sleep apnea diagnosis
  • Planned FDA pre-submission for AppySleep LAB in H1 2025
  • Expanding marketing efforts in the U.S. and Canada
Negative
  • None.

Wristband connects to an app on iPhone or Android to detect snoring and activates gentle vibrations, prompting users to change their sleeping position

NEW YORK, Sept. 30, 2024 /PRNewswire/ -- AppYea Inc. (OTCQB: APYP), developer of an innovative wearable solution to monitor sleep apnea and snoring, today announced the launch of the new AppySleep device. AppySleep is the first product to leverage AI for optimal customization of snoring treatment and can also detect irregular breathing patterns.

At this stage of the launch, the app can be downloaded for free. However, using the app requires purchasing the accompanying wristband, available at the company's store (http://www.appysleep.com) or on Amazon for an introductory price of $149. The wristband is delivered to U.S. customers within 72 hours.

Customers who purchase AppySleep during the launch will receive a free access to a personal cloud where they can view their sleep history, statistics, personalized graphs, and track improvements in their snoring and overall sleep quality.

In the coming months, the company plans to expand marketing efforts in the U.S. and Canada.

In addition, Appyea is making progress with the development of AppySleep LAB - a touchless app designed for diagnosing sleep apnea without the need for an overnight stay in sleep labs.

The company estimates that it will pre-submit a request to the FDA of AppySleep LAB during H1 2025.

Bary Molchadsky, Chairman of AppYea, commented on the product launch: "Snoring is a common issue, particularly for individuals over the age of 35, yet there have been no comfortable solutions. AppySleep offers an easy-to-use technological solution with an intuitive interface. Our app listens for breathing patterns and, when continuous snoring is detected, activates a gentle vibration in the wristband that encourages users to shift to a side-sleeping position. After several weeks of use, the vibration helps condition users to sleep in the correct position, significantly reducing snoring. The vibration settings can be customized through the app."

Mr. Molchadsky added: "The app provides users with detailed reports and graphs, allowing them to monitor the reduction of snoring over time as well as track other important parameters, including irregular breathing patterns."

The company's online store also offers detailed instructions on how to use the product, along with instructional videos: https://appysleep.com/how-it-works.

Market Overview:

  • According to Precedence Research, the Sleep Tech Devices Market was valued at USD 21.10 billion in 2023 and is expected to reach USD 113.16 billion by 2033, growing at a CAGR of 18.23% from 2024 to 2033. The wearables segment held the largest market share, approximately 76%, in 2023 and is expected to maintain its dominance throughout the forecast period.
  • Fior Markets reports that the Global Anti-Snoring Treatment Market is projected to grow from USD 4.3 billion in 2020 to USD 8.6 billion by 2028, reflecting a CAGR of 9.07% during the period from 2021 to 2028.
  • Fior Markets also estimates that the Global Sleep Apnea Devices Market will reach USD 6.4 billion by 2025.

About AppYea

AppYea is a Healthtech company commercializing innovative wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The Company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost.

Cautionary Note Regarding Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, the going concern qualification in our financials, timing of product development, the success of the new App, customer acceptance of our products in the market, the introduction of competitive products, the effectiveness of our product distribution networks, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 1, 2024, as subsequently supplemented. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com

Photo - https://mma.prnewswire.com/media/2519232/QRCODE_AppySleep.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/appyea-launches-smart-biofeedback-based-wristband-to-address-snoring-302262522.html

SOURCE AppYea Inc.

FAQ

What is the price of AppYea's AppySleep wristband?

The AppySleep wristband is available for an introductory price of $149 on the company's website and Amazon.

When does AppYea (APYP) plan to submit AppySleep LAB to the FDA?

AppYea estimates it will pre-submit a request to the FDA for AppySleep LAB during the first half of 2025.

How does the AppySleep wristband work to reduce snoring?

The AppySleep wristband detects snoring through the app and activates gentle vibrations to encourage users to shift to a side-sleeping position, helping to reduce snoring over time.

What is the projected market size for Sleep Tech Devices by 2033?

According to Precedence Research, the Sleep Tech Devices Market is expected to reach USD 113.16 billion by 2033, growing at a CAGR of 18.23% from 2024 to 2033.

APPYEA INC

OTC:APYP

APYP Rankings

APYP Latest News

APYP Stock Data

7.13M
298.82M
37.12%
Software - Application
Technology
Link
United States of America
Gan Yavne